IRCT20180426039421N1RecruitingPhase 3
Evaluation of the Effect of Melatonin Drug in Decreasing Fatigue Caused by Adjuvant Radiotherapy and Chemotherapy in Women with Breast Cancer: A Clinical Trial
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 64
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to no limit (—)
- Sex
- Female
Inclusion Criteria
- •Breast Cancer Stages I, II, III According to Pathological Reports
- •Patients at least 18 Years Old
- •Have Signed a Written Consent
- •Recevieng Adjuvant Chemotherapy and Radiotherapy
- •No Untreated Hypercalcemia
- •No Systolic Blood Pressure Less Than 100 mm Hg
- •No Warfarin Consumption
- •No Methylphenidate Consumption
- •No Sleep Pills During Melatonin Use
- •No TSH>5/5 or <0/5
- •No Pregnancy or Breastfeeding
Exclusion Criteria
- •Expired During Treatment
- •Stop Using Melatonin during Treatment
Investigators
Similar Trials
Not yet recruiting
Phase 3
The investigation of the Effect of Melatonin Supplement on DermatitisDermatitis.IRCT20220331054378N1Alborz University of Medical Sciences80
Not yet recruiting
Phase 3
Evaluation of the effect of melatonin on COVID 19IRCT20210411050925N1Iran University of Medical Sciences100
Recruiting
Phase 3
Protective effect of Melatonin on clinical outcomes in patients with acute ischemic strokeIRCT20231220060484N1Islamic Azad University70
Recruiting
Phase 2
Melatonin in medium brain traumaModerate brain trauma.Diffuse traumatic brain injuryS06.2IRCT20221108056446N5Esfahan University of Medical Sciences200
Recruiting
Phase 3
Evaluation of the effect of melatonin in the treatment of problems caused by androgen deprivation therapy in prostate cancer patientsIRCT20180722040556N5Esfahan University of Medical Sciences66